Stockreport

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals [Yahoo! Finance]

Lipocine Inc.  (LPCN) 
Last lipocine inc. earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.lipocine.com
PDF System (CNS) disorders, today announced that commercialization of TLANDO® in the U.S. has been transitioned to its licensee Verity Pharma, effective February 1, 2024 , e [Read more]